Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-09
2000-08-15
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514399, 514400, 514427, 546343, 546378, 5483401, 5483461, A61P 300, A61P 910, A61K 31435, A61K 314164, A61R 3140
Patent
active
061037338
ABSTRACT:
An HDL cholesterol level inducing compound and a method of administering the compound having the structural formula I. ##STR1## wherein n is 1 or 2;
R.sub.1 is a heteroaromatic substituent independently selected from a five-membered heteroaromatic ring having at least one N heteroatom, a six-membered heteroaromatic ring having at least one N heteroatom, or a fused ring system having at least one five-membered heteroaromatic ring having at least one N heteroatom;
R.sub.2 is independently selected from --H or phenyl; and
R.sub.3 is independently selected from --H, --CH.sub.3, --OH, phenyl, phenyl substituted with Cl, OCH.sub.3, CH.sub.3, or F, fused phenyl ring system, or six-membered heteroaromatic ring having at least one N heteroatom.
REFERENCES:
patent: 3321366 (1967-05-01), Mussell et al.
patent: 3660577 (1972-05-01), Buchel, I et al.
patent: 3691192 (1972-09-01), Buchel, II et al.
patent: 3705172 (1972-12-01), Buchel, III et al.
patent: 3711497 (1973-01-01), Buchel, IV et al.
patent: 3711498 (1973-01-01), Buchel, V et al.
patent: 3833603 (1974-09-01), Buchel, VI et al.
patent: 3836540 (1974-09-01), Van Der Selt et al.
patent: 4343811 (1982-08-01), Hurnaus et al.
patent: 4891220 (1990-01-01), Donzis
patent: 4916126 (1990-04-01), Traxler et al.
patent: 4975456 (1990-12-01), Creger et al.
patent: 4994465 (1991-02-01), Trivedi
patent: 5001148 (1991-03-01), Saunders et al.
patent: 5011859 (1991-04-01), Jarvi et al.
patent: 5091540 (1992-02-01), Molinari
patent: 5132424 (1992-07-01), Larsen et al.
patent: 5153226 (1992-10-01), Chucholowski et al.
patent: 5157025 (1992-10-01), Aberg et al.
patent: 5166398 (1992-11-01), Creger
patent: 5173487 (1992-12-01), Saunders et al.
patent: 5180717 (1993-01-01), Gammill et al.
patent: 5200424 (1993-04-01), Granzer et al.
patent: 5204373 (1993-04-01), Pearce
patent: 5212164 (1993-05-01), Biller et al.
patent: 5248688 (1993-09-01), Dudrick
patent: 5278171 (1994-01-01), Wannamaker et al.
patent: 5288757 (1994-02-01), Picard et al.
patent: 5296508 (1994-03-01), Pearce
patent: 5298497 (1994-03-01), Tschollar et al.
patent: 5304548 (1994-04-01), Gammill et al.
patent: 5312814 (1994-05-01), Biller et al.
patent: 5348964 (1994-09-01), Barney et al.
patent: 5350758 (1994-09-01), Wannamaker et al.
patent: 5364644 (1994-11-01), Walaszek et al.
patent: 5391765 (1995-02-01), Pearce et al.
patent: 5393776 (1995-02-01), Pearce
Cozzi et al., "N-Imadazolylchroman-4-ones, N-Imidazolyl-1-tetralones, and Their Alcohols as Hypolipemic Agents Raising High-Density Lipoproteins", J. Med. Chem. 29, pp. 404-410 (1986).
Slama et al., "Influence of Some Novel N-Substituted Azoles and Pyridines on Rat Hepatic CYP3A Activity", Biochemical Pharmacology, vol. 55, pp. 1881-1892 (1998).
Bachmann Kenneth A.
Slama James T.
LandOfFree
Method for increasing HDL cholesterol levels using heteroaromati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for increasing HDL cholesterol levels using heteroaromati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for increasing HDL cholesterol levels using heteroaromati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2007232